Clinical Trial Update: FFRangio Accuracy vs. Standard FFR

View source ↗

Summary

A completed clinical trial comparing FFRangio accuracy to standard fractional flow reserve in patients with coronary artery disease, sponsored by CathWorks Ltd.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• FFRangio

Snippet

Sponsor: CathWorks Ltd. | Conditions: Coronary Artery Disease | Status: COMPLETED